UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000024565
Receipt number R000028264
Scientific Title Plasma orexin level in patients with delirium
Date of disclosure of the study information 2016/10/26
Last modified on 2019/04/30 17:20:00

No. Disposal Last modified on Item of update
1 Insert 2016/10/26 10:36:05
2 Update 2016/10/26 10:42:07 Date of disclosure of the study information
3 Update 2016/11/07 13:11:35 Basic objectives -Others
Basic objectives -Others
4 Update 2016/11/07 13:27:02 Study type
Basic design
Randomization
Blinding
Control
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_1
5 Update 2016/11/07 13:28:40 Other related information
Other related information
6 Update 2017/11/12 12:35:58 Public title
Public title
Acronym
Acronym
7 Update 2017/11/12 13:27:44 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
8 Update 2017/11/12 13:28:12 Public title
Acronym
9 Update 2017/11/12 13:46:57 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
10 Update 2017/11/12 13:50:52 Recruitment status
Date of protocol fixation
Anticipated trial start date
11 Update 2018/04/30 13:49:01 Research ethics review
12 Update 2018/04/30 14:01:31 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Results
Results
13 Update 2019/04/30 16:55:19 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
14 Update 2019/04/30 17:18:24 Recruitment status
Date of IRB
15 Update 2019/04/30 17:20:00 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures